Erik Koehne

Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial

Peter G. Kremsner, Rodolfo Andrés Ahuad Guerrero, Eunate Arana‐Arri et al. · The Lancet Infectious Diseases · 2021 · 170 citations · Full text

Monitoring the threatened utility of malaria rapid diagnostic tests by novel high-throughput detection of Plasmodium falciparum hrp2 and hrp3 deletions: A cross-sectional, diagnostic accuracy study

Andrea Kreidenweiss, Franziska Leonie Trauner, Miriam Rodi et al. · EBioMedicine · 2019 · 26 citations · Full text

Engineering, Plasmodium Falciparum Hrp2, Malaria +24

Monitoring of efficacy, tolerability and safety of artemether–lumefantrine and artesunate–amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial

Bayodé Roméo Adégbitè, Jean Ronald Edoa, Yabo Josiane Honkpéhèdji et al. · Malaria Journal · 2019 · 24 citations · Full text

DNA recovery from archived RDTs for genetic characterization of Plasmodium falciparum in a routine setting in Lambaréné, Gabon

Nguyen Trong The, Brice Nzigou Mombo, Albert Lalremruata et al. · Malaria Journal · 2019 · 17 citations · Full text

Histone deacetylase inhibitors with high in vitro activities against Plasmodium falciparum isolates collected from Gabonese children and adults

Erik Koehne, Andrea Kreidenweiss, Rella Zoleko Manego et al. · Scientific Reports · 2019 · 14 citations · Full text